New drug ICP-332 passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug called ICP-332 in 24 healthy adults. Participants received multiple doses of the drug or a placebo to see if it caused any side effects. The goal was to gather initial safety information before testing the drug in people with…
Phase: PHASE1 • Sponsor: InnoCare Pharma Inc. • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC